Testing effectiveness (Phase 2)Study completedNCT02558894
What this trial is testing
Phase II Study of MEDI4736 Monotherapy or in Combinations With Tremelimumab in Metastatic Pancreatic Ductal Carcinoma
Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma
AstraZeneca 65